Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Mailing Lists / Archive General Hot Articles / 2005-12-21

Best wishes for the holidays from Hot Neuron.

In this issue:  Questionable R&D, a loss for intelligent
design, and diluted drugs.

Companies that pump more money into R&D do not show better
results, in terms of growth or profitability, according to
Bank Systems & Technology points out the need for business
continuity plans to prepare for the possibility of a major
flue outbreak.
Faulty spreadsheets and poor spreadsheet practices have been
implicated in a wide variety of business and financial
problems, according to Science News.
The American Prospect tells how one Wal-Mart true believer
was excommunicated for his faith in doing what he thought
the company expected of him: crying foul.  Today Lynn is one
of several prominent whistle-blowers suing the company in
high-profile unjust-termination cases.
The Motley Fool says DuPont paid the largest civil fine ever
levied over a chemical used to make Teflon.

A Pennsylvania judge ruled that the Dover Area School
District's science curriculum, which required the
presentation of intelligent design as an alternative to
evolution, is unconstitutional, according to Geotimes.

Why pay for things like doctors' bills, disability
insurance, and baby-sitting if your boss is willing to pick
up the tab?  The Motley Fool explains how to milk your
employer for every last penny that is rightfully yours.

Make your website more dynamic with feeds from MagPortal

In King Kong, Peter Jackson's most significant triumph in
our age of visual oversaturation is that he creates images
worth falling in love with, according to Eye.
Culture Vulture reviews Memoirs of a Geisha, a film set in
pre-World War II Japan that relates the tale of how a poor
young girl from a fishing village became the most renowned
geisha in all Kyoto.
The film adaptation of The Producers, starring Matthew
Broderick and Nathan Lane, strikes a perfect balance between
silliness and levity, according to Culture Vulture.

The Motley Fool reports that a scandal involving the biggest
gem-certifying lab, the Gemological Institute of America,
has the diamond industry fretting over the potential impact.
When fakes of a GlaxoSmithKline anti-malarial drug turned up
in Africa, authorities assumed the company would want to
know.  Instead, The American Prospect says they learned
about a huge, evil trade in fake drugs -- and about an
industry that doesn't want the truth to get out.

So far, NASA's plan to reach Mars has been short on detail. 
Apollo astronaut Buzz Aldrin unveils his own step-by-step
proposal to Popular Mechanics for mankind's next giant leap.

Information Age describes a high resolution visualization
room that helps Los Alamos National Laboratory researchers
simulate large nuclear explosions, replacing the need for
live nuclear testing.